Abstract:Xuemin Liu, Hui Qiu Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, People's Republic of China Correspondence: Hui Qiu, Email Gestational diabetes mellitus (GDM) refers to different degrees of glucose metabolism abnormalities that occur or be first discovered during pregnancy. It is closely related to many adverse pregnancy outcomes. Placenta-specific exosomes are one kind of extracellular vesicles which are only produced by the placenta. These exosomes participate in many physiological and pathological processes of the body through the contained RNA, lipids, proteins, and DNA. In gestational diabetes, the placental exosomes play an important role in the occurrence and development of gestational diabetes through regulating insulin resistance, inflammatory factors, and endothelial cell dysfunction. In this review, we will discuss the generation, changes, and mechanism of placenta-specific exosomes in GDM, as well as their prospects as a predictive and therapeutic target for gestational diabetes. Keywords: pregnancy, gestational diabetes, exosome, placenta Gestational Diabetes Mellitus (GDM) refers to different degrees of glucose metabolism abnormalities that occur or be first discovered during pregnancy. 1 It is generally considered to be insulin resistance caused by pancreatic β-cell dysfunction. 2 The frequency of gestational diabetes mellitus at collaborating centers was 17.8% according to the International Association of Diabetes in Pregnancy Study Group criteria. 3 GDM not only increases the risk of gestational hypertension, premature delivery, premature rupture of membranes, fetal malformations, dystocia, cesarean section, etc., but also increases the risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease in offspring. 4–6 Early diagnosis, intervention, and treatment can improve the prognosis of gestational diabetes. At present, the pathogenesis of gestational diabetes is not fully understood. Possible mechanisms include genetics, insulin resistance, autoimmunity, and the release of inflammatory factors. 7–9 Clarifying the pathogenesis of gestational diabetes is of great significance to its diagnosis and treatment. During pregnancy, the placenta participates in the regulation of the endocrine system by secreting a variety of substances including exosomes. The role of placenta-derived exosomes in the etiology and progression of complications of pregnancy is still in a formative stage. This article summarizes the research progress of placenta-derived exosomes and GDM for providing new ideas for the pathogenesis and prevention of GDM. Figure 1 The functions and mechanisms of pdE in GDM. In gestational diabetes, hypoxia, high glucose, and BMI affect the production of placental exosomes, which in turn regulate insulin resistance, inflammatory factors, and endothelial cell dysfunction. These factors work together to promote the occurrence and development of diabetes and fetal growth and development. The placenta is an important organ for the exchange of substances between the fetus and the mother. The placental barrier can also shield the fetus from harmful substances; In addition, the placenta synthesizes a variety of enzymes, hormones, and cytokines to maintain normal pregnancy. 10 It is estimated that 69% of all human proteins are expressed in the placenta and most of them are associated with pregnancy, estrogen biosynthetic, and metabolic pathways. 11 During pregnancy, the placenta secretes many insulin-resistant hormones such as placental prolactin, estrogen, progesterone, and adrenal cortex hormones. 12 As pregnancy progresses, the secretion of placental hormones gradually increases, making pregnancy a physiological insulin resistance state. Glucose metabolism is characterized by increased glycogen production and decreased utilization of glucose by tissues, which smooths the transfer of nutrition to the fetus. 13–16 When facing insulin resistance, normal pregnant women can secrete enough insulin to supply the body's needs, while a small number of pregnant women with defective β cell function cannot secrete so much insulin, unable to overcome insulin resistance, leading to gestational diabetes. At the same time, maternal hyperglycemia affects the structure of the placenta and the distribution of blood vessels and increases maternal and fetal complications. 17–20 Therefore, the placenta plays an important role in the occurrence and development of gestational diabetes. Exosomes are one kind of extracellular vesicles (EVs). Extracellular vesicles are derived from membranes in almost all cells and participate in the regulation of human functions through the contained RNA, lipids, proteins, -Abstract Truncated-

Adipose stem cells-derived small extracellular vesicles transport Thrombospondin 1 cargo to promote insulin resistance in gestational diabetes mellitus

Gestational Diabetes Mellitus-Associated Hyperglycemia Impairs Glucose Transporter 3 Trafficking in Trophoblasts Through the Downregulation of AMP-Activated Protein Kinase.

Nesfatin-1 alleviates high glucose/high lipid-induced injury of trophoblast cells during gestational diabetes mellitus

Placenta-Derived Exosomes and Gestational Diabetes Mellitus

Intrauterine Exposure to Hyperglycemia Retards the Development of Brown Adipose Tissue

Targeting Adrenomedullin to Improve Lipid Homeostasis in Diabetic Pregnancies

IGF1R stimulates autophagy, enhances viability, and promotes insulin secretion in pancreatic β cells in gestational diabetes mellitus by upregulating ATG7

Non-Coding RNAs and Extracellular Vehicles: Their Role in the Pathogenesis of Gestational Diabetes Mellitus

Protective Effects of Villi Mesenchymal Stem Cells on Human Umbilical Vein Endothelial Cells by Inducing SPOCD1 Expression in Cases of Gestational Diabetes Mellitus.

Identification of A Novel Function of Adipocyte Plasma Membrane Associated Protein (apmap) in Gestational Diabetes Mellitus by Proteomic Analysis of Omental Adipose Tissue

Downregulated ABHD5 Aggravates Insulin Resistance of Trophoblast Cells During Gestational Diabetes Mellitus

Oligopeptide-strategy of targeting at adipose tissue macrophages using ATS-9R/siCcl2 complex for ameliorating insulin resistance in GDM

Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells

Human gestational diabetes mellitus-derived exosomes impair glucose homeostasis in pregnant mice and stimulate functional maturation of offspring-islets

A novel technique using chronic infusion of small extracellular vesicles from gestational diabetes mellitus causes glucose intolerance in pregnant mice

Comparison of serum vaspin levels and vaspin expression in adipose tissue and smooth muscle tissue in pregnant women with and without gestational diabetes.

sh- Ambra1 inhibits IRS-1/PI3K/Akt signalling pathway to reduce autophagy in gestational diabetes

Lipid dysfunction and adrenomedullin expression in omental versus subcutaneous adipose tissues in diabetic pregnancies

Placental small extracellular vesicles from normal pregnancy and gestational diabetes increase insulin gene transcription and content in β cells

Stromal Cell-Derived Factor (SDF) 2 and the Endoplasmic Reticulum Stress Response of Trophoblast Cells in Gestational Diabetes Mellitus and In vitro Hyperglycaemic Condition

The link between gestational diabetes and cardiovascular diseases: potential role of extracellular vesicles